Dark Mode
Antipsychotic Medication Feedback Dataset
Patient Health Records & Digital Health
Tags and Keywords
Trusted By
"No reviews yet"
Free
About
Discovering the Realities of Abilify: An Analysis of Patient Reviews and Outcome
A detailed collection of patient experiences and reviews concerning Abilify, an atypical antipsychotic medication prescribed primarily for mental health conditions such as schizophrenia, bipolar disorder, and major depressive disorder. This data contains over 1,000 unique patient accounts designed to provide valuable insights into real-world outcomes. The reviews cover key patient concerns including effectiveness, reported side effects, specific dosage information, and overall satisfaction levels. The resource supports researchers and healthcare professionals seeking to uncover patterns and trends related to medication usage, ultimately contributing to improved patient care practices.
Columns
- Time of Meditation: The date and time at which the patient submitted their review. The most common duration reported is 1 to 6 months.
- Suspect name: The first name of the patient who submitted the review, with 'Anonymous' being the most frequent entry.
- Age: The age of the patient at the time of the review, where the 45-54 age bracket is the most frequently observed.
- Gender: The reported gender of the patient, with Female reviewers making up 69% of the valid entries.
- Suspect Status: Indicates the role of the person submitting the review, predominantly 'Patient' (86%) rather than 'Caregiver' (8%).
- Date: The specific date stamp of the review submission.
- Condition: The specific diagnosis or indication for which Abilify was prescribed. 'Additional Medications to Treat Depression' is the most common condition cited (42%).
- overall-rating: A rating scale from 1 to 5, reflecting the user's overall satisfaction with the medication.
- description-text: The narrative, free-text field detailing the patient’s individual experience.
Distribution
The patient experience data is structured in a tabular format and delivered as a CSV file named
abilify_ora_effected_peple_reviewl.csv, with a file size of approximately 567.29 kB. The structure consists of 9 columns. There are 1,835 valid records available for analysis. The mean overall satisfaction rating is 3.38 out of 5. The data is generally clean, with high validity across key fields, though approximately 16% of the description-text fields are missing. The expected update frequency for this resource is monthly.Usage
- Analysing patterns, trends, and potential issues related to Abilify usage in a non-clinical setting.
- Performing sentiment analysis on the textual review data to gauge public perception of the medication.
- Investigating the relationship between patient demographics, underlying conditions, and reported side effects.
- Informing pharmaceutical monitoring and post-market surveillance activities.
Coverage
The data collection spans a substantial time range, from 18 September 2007 through to 13 February 2023. Demographic representation shows that 69% of the reviewers are Female, and the most common age group is 45-54. Regarding clinical coverage, the most cited condition is the use of additional medications to treat depression.
License
CC0: Public Domain
Who Can Use It
- Medical Researchers: For conducting observational studies on medication efficacy and patient reported side effects.
- Data Scientists: Utilising the detailed text descriptions for advanced Natural Language Processing (NLP) models.
- Public Health Analysts: To monitor the real-world impact and satisfaction scores associated with the atypical antipsychotic category.
Dataset Name Suggestions
- Abilify Patient Experiences and Outcomes (2007-2023)
- Real-World Patient Reviews of Abilify
- Antipsychotic Medication Feedback Dataset
- Mental Health Drug Experience Repository
Attributes
Original Data Source: Antipsychotic Medication Feedback Dataset
QUALITYLoading...